Tradewinds Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-190
| Closed | -$21.9K | – | 698 |
|
|
2024
Q3 | $21.9K | Buy |
190
+40
| +27% | +$4.54K | 0.01% | 260 |
|
|
2024
Q2 | $16K | Buy |
+150
| New | +$15.1K | ﹤0.01% | 282 |
|
|
2022
Q2 | – | Sell |
-280
| Closed | -$25K | – | 670 |
|
|
2022
Q1 | $25K | Buy |
280
+15
| +6% | +$1.3K | ﹤0.01% | 340 |
|
|
2021
Q4 | $23K | Hold |
265
| – | – | ﹤0.01% | 352 |
|
|
2021
Q3 | $22K | Sell |
265
-29
| -10% | -$2.61K | ﹤0.01% | 352 |
|
|
2021
Q2 | $27K | Hold |
294
| – | – | ﹤0.01% | 337 |
|
|
2021
Q1 | $25K | Hold |
294
| – | – | 0.01% | 319 |
|
|
2020
Q4 | $28K | Hold |
294
| – | – | 0.01% | 287 |
|
|
2020
Q3 | $26K | Hold |
294
| – | – | 0.01% | 263 |
|
|
2020
Q2 | $26K | Hold |
294
| – | – | 0.01% | 260 |
|
|
2020
Q1 | $24K | Sell |
294
-27
| -8% | -$2.41K | 0.01% | 236 |
|
|
2019
Q4 | $30K | Buy |
321
+29
| +10% | +$2.6K | 0.01% | 243 |
|
|
2019
Q3 | $25K | Buy |
292
+27
| +10% | +$2.42K | 0.01% | 247 |
|
|
2019
Q2 | $24K | Sell |
265
-31
| -10% | -$2.62K | 0.01% | 254 |
|
|
2019
Q1 | $25K | Hold |
296
| – | – | 0.01% | 260 |
|
|
2018
Q4 | $23K | Hold |
296
| – | – | 0.01% | 260 |
|
|
2018
Q3 | $23K | Hold |
296
| – | – | 0.01% | 300 |
|
|
2018
Q2 | $20K | Hold |
296
| – | – | 0.01% | 314 |
|
|
2018
Q1 | $21K | Hold |
296
| – | – | 0.01% | 295 |
|
|
2017
Q4 | $22K | Sell |
296
-23
| -7% | -$1.74K | 0.01% | 301 |
|
|
2017
Q3 | $25K | Hold |
319
| – | – | 0.01% | 273 |
|
|
2017
Q2 | $24K | Sell |
319
-36
| -10% | -$2.55K | 0.01% | 269 |
|
|
2017
Q1 | $24K | Buy |
355
+296
| +502% | +$19.7K | 0.02% | 274 |
|
|
2016
Q4 | $4K | Sell |
59
-666
| -92% | -$43.2K | ﹤0.01% | 468 |
|
|
2016
Q3 | $51K | Buy |
725
+14
| +2% | +$1.02K | 0.04% | 187 |
|
|
2016
Q2 | $53K | Hold |
711
| – | – | 0.04% | 190 |
|
|
2016
Q1 | $46K | Hold |
711
| – | – | 0.03% | 227 |
|
|
2015
Q4 | $55K | Sell |
711
-68
| -9% | -$5.4K | 0.04% | 205 |
|
|
2015
Q3 | $64K | Buy |
779
+36
| +5% | +$3.2K | 0.05% | 186 |
|
|
2015
Q2 | $65K | Hold |
743
| – | – | 0.05% | 199 |
|
|
2015
Q1 | $66K | Hold |
743
| – | – | 0.05% | 183 |
|
|
2014
Q4 | $62K | Hold |
743
| – | – | 0.04% | 183 |
|
|
2014
Q3 | $63K | Hold |
743
| – | – | 0.05% | 184 |
|
|
2014
Q2 | $60K | Hold |
743
| – | – | 0.05% | 198 |
|
|
2014
Q1 | $57K | Hold |
743
| – | – | 0.05% | 208 |
|
|
2013
Q4 | $54K | Buy |
+743
| New | +$51.6K | 0.04% | 201 |
|
Other funds holding NVS
Tradewinds Capital Management's NVS Position: Q4 2024 in Review
Tradewinds Capital Management sold out of Novartis (NVS) in Q4 2024, closing a stake of 190 shares — an estimated $21.9K sold.
Tradewinds Capital Management first reported a position in NVS in Q4 2013 and held it in 36 quarters. The position peaked at $66K in Q1 2015. 1,342 funds tracked by Wall St. Rank hold NVS as of Q4 2024.
- Tradewinds Capital Management reported no remaining Novartis position as of Q4 2024 after selling out during the quarter.
- Tradewinds Capital Management sold 190 Novartis shares in Q4 2024, an estimated $21.9K.
- Tradewinds Capital Management first reported a position in Novartis in Q4 2013 and held it in 36 quarters.
- Tradewinds Capital Management's Novartis position peaked at $66K in Q1 2015.
- 1,342 funds tracked by Wall St. Rank held Novartis as of Q4 2024.
Based on Tradewinds Capital Management's 13F filing for Q4 2024, filed 4 Feb 2025.